FOX RUN MANAGEMENT, L.L.C. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
FOX RUN MANAGEMENT, L.L.C. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$668,882
+99.1%
17,510
+129.2%
0.20%
+17.9%
Q2 2022$336,000
+122.5%
7,639
-25.9%
0.17%
+110.0%
Q4 2018$151,000
-53.7%
10,313
-42.6%
0.08%
-43.7%
Q3 2018$326,000
+34.2%
17,965
+44.5%
0.14%
+140.7%
Q1 2018$243,000
-68.7%
12,429
-67.6%
0.06%
-74.1%
Q4 2017$777,000
+164.3%
38,345
+126.9%
0.23%
+174.7%
Q3 2017$294,00016,9000.08%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders